Research & Clinical Programs

STRATEGIC PARTNERSHIPS

Partnerships with Top Pharmaceutical Companies, Federal and State Agencies, and major Epilepsy Academic Centers.

STRATEGIC PARTNERSHIPS

Partnerships with Top Pharmaceutical Companies, Federal and State Agencies, and major Epilepsy Academic Centers.

CAPABILITIES

R & D Capabilities: Biom’s R & D capabilities includes state-of-the art biomedical research facility and a team of biomedical researchers. We have a dosage formulation lab to develop various forms of pharmaceutical-grade formulation.

PRE-CLINICAL PROGRAMS

We are testing our lead candidates for three indications (rare epilepsies, Autism spectrum disorders, Alzheimers) in preclinical animal models to validate therapeutically significant outcome measures.

Rare Epilepsies

Autism Spectrum Disorders

Alzheimer’s Disease